Figure 2.
(A) Dose regimen for hepatic arterial infusion of CAR-T cells without IL2. (B) Dose regimen for hepatic arterial infusion of CAR-T cells with IL2 co-treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.